Li Li1, Hui Sun1, Jie Ding1, Chenxu Niu1, Min Su1, Ludi Zhang1, Yingmin Li2, Chuan Wang1, Nikita Gamper1,3, Xiaona Du1, Hailin Zhang1. 1. Department of Pharmacology; The Key Laboratory of Neural and Vascular Biology, Ministry of Education; The Key Laboratory of New Drug Pharmacology and Toxicology, Hebei Medical University, Shijiazhuang, Hebei, China. 2. Department of Forensic Medicine, Hebei Medical University, Shijiazhuang, Hebei, China. 3. Faculty of Biological Sciences, University of Leeds, Leeds, UK.
Abstract
BACKGROUND AND PURPOSE: The mesolimbic dopamine system originating in the ventral tegmental area (VTA) is involved in the development of depression, and firing patterns of VTA dopaminergic neurons are key determinants in this process. Here, we describe a crucial role for the M-type Kv 7.4 channels in modulating excitability of VTA dopaminergic neurons and in the development of depressive behaviour in mice. EXPERIMENTAL APPROACH: We used Kv 7.4 channel knockout mice and a social defeat model of depression in combination with electrophysiological techniques (patch clamp recording and in vivo single-unit recordings), immunohistochemistry, single-cell PCR and behavioural analyses (social interaction time and glucose preference tests) to investigate VTA circuits involved in the development of depression-like behaviour. KEY RESULTS: Among the Kv 7 channels, Kv 7.4 channels are selectively expressed in dopaminergic neurons of the VTA. Using a newly identified selective Kv 7.4 channel activator, fasudil, and Kv 7.4 channel knockout mice, we demonstrate that these channels are a dominant modulator of excitability of VTA dopaminergic neurons, in vitro and in vivo. Down-regulation of Kv 7.4 channels could be a causal factor of the altered excitability of VTA dopaminergic neurons and depression-like behaviour. The selective Kv 7.4 channel activator, fasudil, strongly alleviated depression-like behaviour in the social defeat mouse model of depression. CONCLUSION AND IMPLICATIONS: Because expression of Kv 7.4 channels in the CNS is limited, selectively targeting this M channel subunit is likely to produce less on-target side effects than non-selective M channel modulators. Thus, Kv 7.4 channels may offer alternative targets in treatment of depression.
BACKGROUND AND PURPOSE: The mesolimbic dopamine system originating in the ventral tegmental area (VTA) is involved in the development of depression, and firing patterns of VTA dopaminergic neurons are key determinants in this process. Here, we describe a crucial role for the M-type Kv 7.4 channels in modulating excitability of VTA dopaminergic neurons and in the development of depressive behaviour in mice. EXPERIMENTAL APPROACH: We used Kv 7.4 channel knockout mice and a social defeat model of depression in combination with electrophysiological techniques (patch clamp recording and in vivo single-unit recordings), immunohistochemistry, single-cell PCR and behavioural analyses (social interaction time and glucose preference tests) to investigate VTA circuits involved in the development of depression-like behaviour. KEY RESULTS: Among the Kv 7 channels, Kv 7.4 channels are selectively expressed in dopaminergic neurons of the VTA. Using a newly identified selective Kv 7.4 channel activator, fasudil, and Kv 7.4 channel knockout mice, we demonstrate that these channels are a dominant modulator of excitability of VTA dopaminergic neurons, in vitro and in vivo. Down-regulation of Kv 7.4 channels could be a causal factor of the altered excitability of VTA dopaminergic neurons and depression-like behaviour. The selective Kv 7.4 channel activator, fasudil, strongly alleviated depression-like behaviour in the social defeat mouse model of depression. CONCLUSION AND IMPLICATIONS: Because expression of Kv 7.4 channels in the CNS is limited, selectively targeting this M channel subunit is likely to produce less on-target side effects than non-selective M channel modulators. Thus, Kv 7.4 channels may offer alternative targets in treatment of depression.
Authors: Claire L Padgett; Arnaud L Lalive; Kelly R Tan; Miho Terunuma; Michaelanne B Munoz; Menelas N Pangalos; José Martínez-Hernández; Masahiko Watanabe; Stephen J Moss; Rafael Luján; Christian Lüscher; Paul A Slesinger Journal: Neuron Date: 2012-03-08 Impact factor: 17.173
Authors: Kay M Tye; Julie J Mirzabekov; Melissa R Warden; Emily A Ferenczi; Hsing-Chen Tsai; Joel Finkelstein; Sung-Yon Kim; Avishek Adhikari; Kimberly R Thompson; Aaron S Andalman; Lisa A Gunaydin; Ilana B Witten; Karl Deisseroth Journal: Nature Date: 2012-12-12 Impact factor: 49.962
Authors: Stephen Ph Alexander; John A Peters; Eamonn Kelly; Neil Marrion; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies Journal: Br J Pharmacol Date: 2015-12 Impact factor: 8.739
Authors: Sara Costi; Laurel S Morris; Katherine A Kirkwood; Megan Hoch; Morgan Corniquel; Brittany Vo-Le; Tabish Iqbal; Nisha Chadha; Diego A Pizzagalli; Alexis Whitton; Laura Bevilacqua; Manish K Jha; Stefan Ursu; Alan C Swann; Katherine A Collins; Ramiro Salas; Emilia Bagiella; Michael K Parides; Emily R Stern; Dan V Iosifescu; Ming-Hu Han; Sanjay J Mathew; James W Murrough Journal: Am J Psychiatry Date: 2021-03-03 Impact factor: 18.112
Authors: Tamer M Gamal El-Din; Timothy Lantin; Christopher W Tschumi; Barbara Juarez; Meagan Quinlan; Julia H Hayano; Jin Li; Larry S Zweifel; William A Catterall Journal: Proc Natl Acad Sci U S A Date: 2021-11-09 Impact factor: 11.205